Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Paul James Scopa


  • Director at Adverum Biotechnologies Inc. (ADVM), 2019-08-16
  • Director at Conatus Pharmaceuticals Inc. (CNAT), 2018-06-25
  • Other at Radius Health Inc. (RDUS), 2016-09-29
  • Large Shareholder at Syndax Pharmaceuticals Inc (SNDX), 2016-03-09
  • Director at Trivascular Technologies Inc. (TRIV), 2016-02-04
  • Large Shareholder at Cerecor Inc. (CERC), 2015-10-20
  • Large Shareholder at Chiasma Inc (CHMA), 2015-07-21
  • Large Shareholder at Aratana Therapeutics Inc. (PETX), 2014-03-12
  • Large Shareholder at Epizyme Inc. (EPZM), 2014-02-11
  • Other at Pacira Pharmaceuticals Inc. (PCRX), 2013-03-13
  • Other at Verastem Inc. (VSTM), 2012-02-03
  • Large Shareholder, Director at Peplin Inc (PLI), 2009-11-13
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ADVM $6.71 20,000 Director 20,000 2019-05-06 Filing
CNAT $11.00 165,265 Director 1,192,080 2013-07-30 Filing
PLI $8.20 1,249 Large Shareholder, Director 2,899,256 2009-02-12 Filing
PLI $8.00 999 Large Shareholder, Director 2,898,007 2009-02-11 Filing
PLI $8.00 999 Large Shareholder, Director 2,897,008 2009-02-09 Filing